BioScience Health Innovations (BHIC) Invested Capital (2019 - 2022)

BioScience Health Innovations (BHIC) has reported Invested Capital for 3 consecutive years, with $8713.0 the latest figure, recorded in Q4 2021.

• In Q4 2021, Invested Capital rose 23.57% year-over-year to $8713.0; the TTM figure through Aug 2022 stood at $8713.0 (down 65.49% YoY), while the FY2021 annual figure was $2893.0, down 58.97% from the prior year.
• Invested Capital advanced to $8713.0 in Q4 2021 per BHIC's latest filing, from $2893.0 in the prior quarter.
• Across five years, Invested Capital topped out at $8713.0 in Q4 2021 and bottomed at $2893.0 in Q3 2021.
• Historically, Invested Capital has averaged $6637.9 across 3 years, with a median of $7051.0 in 2020.
• On a YoY basis, Invested Capital climbed as much as 28.9% in 2021 and fell as far as 58.97% in 2021.
• BioScience Health Innovations' Invested Capital stood at $6115.0 in 2019, then increased by 15.31% to $7051.0 in 2020, then grew by 23.57% to $8713.0 in 2021.
• Business Quant data shows BHIC's Invested Capital at $8713.0 in Q4 2021, $2893.0 in Q3 2021, and $8251.0 in Q2 2021.